Scholze J, Rautenberg B, Hansen A
Medizinische Universitätspoliklinik Charité, Berlin, Germany.
Dtsch Med Wochenschr. 2002 Nov 8;127(45):2383-6. doi: 10.1055/s-2002-35361.
A 71-year-old woman with arterial hypertension, diabetes type 2, peripheral vascular disease and Sjögren's syndrome presented with progressive weakness, dizziness, insomnia, palpitations and headache. These symptoms did not improve by changing her antihypertensive treatment. The patient's general condition was quite normal and there were no signs of acute or chronic cardiopulmonary decompensation.
Besides arterial hypertension, she also had an elevated body mass index, dyslipoproteinemia, microalbuminuria, diabetic metabolism, left ventricular hypertrophy with signs of an abnormal diastolic cardiac function as well as atherosclerotic lesions (in both carotid arteries) which were identified as the patient's cardiovascular risk factors. Ambulant blood pressure monitoring revealed decreasing BP values for a period of 5 hrs after drug intake but, subsequently, severe hypertensive values (up to 220 mmHg systolic) without adequate decrease at night. Moreover, a hyperkinetic regulation of her circulation was demonstrated by hemodynamic monitoring and assessment of the autonomic nervous system.
By changing drug treatment, i. e. administration of an anti-adrenergic calcium antagonist of the non-dihydropyridine type combined with an ACE inhibitor and a diuretic, respectively, (both given in fixed combinations) led to the normalization of the blood pressure and pulse rate as well as an improvement of the patient's condition.
This case emphasizes the importance of ambulant blood pressure monitoring and an assessment of the heart rate in individually adapted antihypertensive drug therapy. The application of metabolically neutral fixed drug combinations with special regard to associated diseases, organ protection and the patient's compliance resulted in normotensive blood pressure values and an improvement of the quality of life.
一名71岁女性,患有动脉高血压、2型糖尿病、周围血管疾病和干燥综合征,出现进行性虚弱、头晕、失眠、心悸和头痛。改变抗高血压治疗方案后,这些症状并未改善。患者的一般状况相当正常,没有急性或慢性心肺失代偿的迹象。
除动脉高血压外,她还存在体重指数升高、血脂蛋白异常血症、微量白蛋白尿、糖尿病代谢、左心室肥厚并有舒张性心功能异常的迹象,以及(双侧颈动脉)动脉粥样硬化病变,这些被确定为患者的心血管危险因素。动态血压监测显示,服药后5小时血压值下降,但随后出现严重高血压值(收缩压高达220 mmHg),夜间血压没有充分下降。此外,通过血流动力学监测和自主神经系统评估显示她的循环存在高动力调节。
通过改变药物治疗,即分别给予非二氢吡啶类抗肾上腺素能钙拮抗剂与一种ACE抑制剂和一种利尿剂(两者均以固定组合给药),使血压和脉搏率恢复正常,并改善了患者的状况。
该病例强调了动态血压监测和心率评估在个体化调整抗高血压药物治疗中的重要性。应用对代谢无不良影响的固定药物组合,并特别关注相关疾病、器官保护和患者依从性,可使血压值恢复正常并改善生活质量。